Identification of patients at high risk for relapse by Merlin Assay (CP-GEP) in an independent cohort of patients with melanoma who did not undergo sentinel lymph node biopsy: head and neck subgroup analysis

Identification of patients at high risk for relapse by Merlin Assay (CP-GEP) in an independent cohort of patients with melanoma who did not undergo sentinel lymph node biopsy: head and neck subgroup analysis

Saved in:
Bibliographic Details
Main Authors: T. Amaral, E. Chatziioannou, A. Nuebling, T. Sinnberg, H. Niessner, U. Leiter, J. Dwarkasing, T. Arentsen, C. Groß, A. Eggermont, L. Flatz, S. Forchhammer
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:EJC Skin Cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S2772611824001149
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items